Hematology TimesFDA grants orphan designation to drug for AMLDecember 27, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesDrug approved for kids with sickle cell anemiaDecember 24, 2017AnemiaPediatricsPharmacy
Hematology TimesNilotinib label updated with info on discontinuationDecember 23, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesFDA expands approved use of bosutinib in CMLDecember 20, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesHealth Canada approves midostaurin for AMLDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesCompanies launch generic busulfan in USDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesDrug receives fast track designation for FLT3+ rel/ref AMLDecember 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesFDA grants priority review to NDA for avatrombopagNovember 29, 2017AnemiaThrombosisPharmacyBleeding Disorders
Hematology TimesNilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesProduct approved to treat patients with hemophilia A and inhibitorsNovember 17, 2017ThrombosisPharmacyBleeding Disorders
Hematology TimesFDA approves generic clofarabineNovember 16, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesGeneric azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
